Moderna to acquire Japanese biotech firm OriCiro Genomics for $85m

Pallavi Madhiraju- January 5, 2023 0

Moderna has agreed to acquire OriCiro Genomics, a Japanese biotech firm involved in developing cell-free synthesis and amplification of plasmid DNAs for applications in gene ... Read More

Moderna to build mRNA vaccine manufacturing plant in Victoria

pallavi123- December 14, 2021 0

Moderna has signed an agreement in principle with the Government of Australia to build a messenger RNA (mRNA) vaccine manufacturing plant in Victoria. According to ... Read More

US biotech company Moderna to build $500m mRNA facility in Africa

pallavi123- October 9, 2021 0

Moderna will invest up to $500 million to construct a messenger RNA facility (mRNA facility) in Africa with an aim to produce up to 500 ... Read More

Indian government approves use of Moderna’s Covid-19 Vaccine Moderna

pallavi123- June 29, 2021 0

US biotech company Moderna has been given emergency use authorization from the Indian government for its Covid-19 Vaccine Moderna (mRNA-1273) in adults aged 18 years ... Read More

Moderna to supply 7m more doses of Covid-19 Vaccine Moderna to Philippines

pallavi123- March 22, 2021 0

Moderna has agreed to supply the Philippines with seven million additional doses of Covid-19 Vaccine Moderna, to take the confirmed order commitment to the Asian ... Read More

US FDA authorizes Moderna Covid-19 vaccine mRNA-1273

pharmanewsdaily- December 19, 2020 0

Moderna Covid-19 vaccine : The US Food and Drug Administration (FDA) has given emergency use authorization (EUA) for mRNA-1273, the messenger RNA (mRNA) Covid-19 vaccine ... Read More

Moderna bags $1.5bn contract to supply mRNA-1273 Covid-19 vaccine to US govt

pharmanewsdaily- August 12, 2020 0

Moderna has bagged a deal worth up to $1.52 billion for the manufacturing and supply of 100 million doses of its mRNA-1273 vaccine candidate for ... Read More

Coronavirus vaccine trial results : Moderna mRNA-1273 shows early promise

pharmanewsdaily- May 19, 2020 0

Moderna said that mRNA-1273, its novel coronavirus vaccine candidate, has delivered positive interim data in a phase 1 clinical trial by eliciting neutralizing antibody titer ... Read More